Your session is about to expire
← Back to Search
Risperidone vs Aripiprazole for Weight Gain in Children with Autism
Study Summary
This trial will compare the weight gain of children taking aripiprazole or risperidone for behavioral dysregulation in autism spectrum disorders.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 17 years old or younger.I have never taken atypical antipsychotics.I have used medication for severe mental health issues.I am 18 years old or older.
- Group 1: Treatment with Risperidone
- Group 2: Treatment with Aripiprazole
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
To what afflictions is treatment with risperidone usually deployed?
"Risperidone is a medication often prescribed to reduce irritability as well as agitation, Alzheimer's disease and Behcet Syndrome."
Are there still openings for volunteers to participate in this research?
"Correct. Data hosted on clinicaltrials.gov reveals that this medical experiment, which was initially posted on February 1st 2022, is actively searching for participants. The study has recently been updated as of March 10th 2022."
Has there been any prior research concerning the utilization of Risperidone?
"Presently, 24 clinical trials are in progress to evaluate the efficacy of risperidone. 6 of those experiments have reached phase 3 status. Most studies for this medication take place in Toronto, Ontario but there are 149 sites participating worldwide."
How many individuals are participating in this experiment?
"Affirmative. Clinicaltrials.gov has information which confirms that this research is currently seeking participants, with the initial post made on February 1st 2022 and most recent update happening March 10th 2022. This trial needs to find 350 individuals from one site in particular."
What risks are associated with administering risperidone to patients?
"With the Phase 4 trial results indicating that Treatment with Risperidone is approved, our team at Power rated its safety a 3 on the 1 to 3 scale."
Share this study with friends
Copy Link
Messenger